Hizentra 20% subcutaneous injection 4g/20mL syringe (YJ code: 6343439G3020, 4g 20mL 1 tube), manufactured by CSL Behring, contains pH 4 treated acidic human immunoglobulin (subcutaneous injection). This medication is used for primary immunodeficiency (PI) and for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
Hizentra 20% subcutaneous injection 4g/20mL syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →